C030046E11Rik Inhibitors
C030046E11Rik, a product of the RIKEN cDNA C030046E11 gene, plays a vital role in cellular processes, potentially including gene expression regulation. While direct inhibitors for C030046E11Rik are not yet identified, exploration of potential inhibitors targeting key signaling pathways reveals intriguing possibilities for further investigation.
Functionally, C030046E11Rik is intricately linked to the MAPK/ERK, p38 MAP kinase, JNK, PI3K-AKT, GSK-3, and TGF-β pathways. These pathways collectively contribute to cellular responses and gene expression dynamics associated with C030046E11Rik. The identified inhibitors, such as U0126, Wortmannin, and SB216763, target these pathways to potentially impact the regulatory mechanisms and gene expression dynamics associated with C030046E11Rik. The MAPK/ERK pathway, vital for cellular growth and differentiation, p38 MAP kinase pathway modulating stress responses, JNK pathway influencing cellular stress responses, PI3K-AKT pathway crucial for cellular survival, GSK-3 signaling pathway, and TGF-β pathway involved in cellular differentiation collectively contribute to the intricate role of C030046E11Rik in cellular homeostasis. The identified inhibitors modulate these pathways, providing a foundation for future investigations into the regulatory intricacies of C030046E11Rik and its potential modulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAP kinase inhibitor, may indirectly influence C030046E11Rik by altering the dynamics of cellular responses crucial for this enigmatic protein through modulation of the MAPK pathway, particularly p38 MAP kinase. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, may indirectly influence C030046E11Rik by suppressing c-Jun N-terminal kinase activity, impacting gene expression dynamics associated with this enigmatic protein through modulation of cellular stress responses. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, another MEK inhibitor, may impact C030046E11Rik by targeting the MAPK/ERK pathway. Its inhibitory action on MEK could disrupt downstream signaling, potentially influencing cellular processes linked to this protein. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, disrupts the PI3K-AKT pathway, potentially influencing cellular processes linked to C030046E11Rik. Its impact on the regulatory mechanisms of this enigmatic protein could lead to alterations in gene expression dynamics. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132, a JNK inhibitor, may indirectly influence C030046E11Rik by suppressing c-Jun N-terminal kinase activity, impacting gene expression dynamics associated with this enigmatic protein through modulation of cellular stress responses. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, disrupts the PI3K-AKT pathway, potentially influencing cellular processes linked to C030046E11Rik. Its impact on the regulatory mechanisms of this enigmatic protein could lead to alterations in gene expression dynamics. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB216763, a GSK-3 inhibitor, may influence C030046E11Rik by disrupting GSK-3 signaling, impacting downstream cellular responses and potentially altering gene expression dynamics associated with this enigmatic protein. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542, a TGF-β receptor inhibitor, may indirectly impact C030046E11Rik by modulating the TGF-β pathway. Its inhibitory action on TGF-β receptors could disrupt downstream signaling, potentially influencing cellular processes linked to this protein. | ||||||
JNK Inhibitor V | 345987-15-7 | sc-202672A sc-202672 | 1 mg 5 mg | $60.00 $169.00 | 3 | |
JNK Inhibitor V may indirectly influence C030046E11Rik by suppressing c-Jun N-terminal kinase activity, impacting gene expression dynamics associated with this enigmatic protein through modulation of cellular stress responses. | ||||||
VX-11e | 896720-20-0 | sc-507301 | 10 mg | $180.00 | ||
VX-11e, an ERK inhibitor, may impact C030046E11Rik by targeting the MAPK/ERK pathway. Its inhibitory action on ERK could disrupt downstream signaling, potentially influencing cellular processes linked to this protein. | ||||||